Nancy Flournoy
#100,880
Most Influential Person Now
American statistician
Nancy Flournoy's AcademicInfluence.com Rankings
Nancy Flournoymathematics Degrees
Mathematics
#6195
World Rank
#8627
Historical Rank
Statistics
#606
World Rank
#687
Historical Rank
Download Badge
Mathematics
Nancy Flournoy's Degrees
- PhD Statistics Stanford University
- Masters Statistics Stanford University
- Bachelors Mathematics University of California, Berkeley
Similar Degrees You Can Earn
Why Is Nancy Flournoy Influential?
(Suggest an Edit or Addition)According to Wikipedia, Nancy Flournoy is an American statistician. Her research in statistics concerns the design of experiments, and particularly the design of adaptive clinical trials; she is also known for her work on applications of statistics to bone marrow transplantation, and in particular on the graft-versus-tumor effect. She is Curators' Distinguished Professor Emeritus of Statistics at the University of Missouri.
Nancy Flournoy's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. (1979) (1527)
- The analysis of failure times in the presence of competing risks. (1978) (1472)
- Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. (1981) (1132)
- One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. (1977) (926)
- Risk factors for cytomegalovirus infection after human marrow transplantation. (1986) (807)
- Marrow transplantation from related donors other than HLA-identical siblings. (1985) (801)
- Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience. (1982) (510)
- Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. (1986) (501)
- Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. (1988) (438)
- Infection with varicella-zoster virus after marrow transplantation. (1985) (355)
- A prospective analysis interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow grafts. (1977) (312)
- Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial. (1982) (289)
- Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. (1983) (262)
- Marrow transplantation for patients with acute lymphoblastic leukemia in remission. (1979) (253)
- Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation (1988) (251)
- Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation. (1984) (234)
- Dose Finding Using the Biased Coin Up‐and‐Down Design and Isotonic Regression (2002) (206)
- Infection with herpes simplex virus and cell-mediated immunity after marrow transplant. (1980) (201)
- Cataracts after total body irradiation and marrow transplantation: a sparing effect of dose fractionation. (1984) (197)
- Risk factors for airflow obstruction in recipients of bone marrow transplants. (1987) (193)
- Cyclosporine as prophylaxis for graft-versus-host disease: a randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia. (1985) (186)
- A random walk rule for phase I clinical trials. (1997) (173)
- Oral manifestations of chronic graft-v-host disease. (1984) (158)
- Antileukemic effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantation. (1981) (139)
- Cytomegalovirus infection and specific cell-mediated immunity after marrow transplant. (1980) (135)
- Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients. (1985) (108)
- Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. (1988) (107)
- Marrow transplantation for chronic myelocytic leukemia: a controlled trial of cyclosporine versus methotrexate for prophylaxis of graft-versus-host disease. (1985) (106)
- A sequential design for maximizing the probability of a favourable response (1998) (103)
- Random Walks for Quantile Estimation (1994) (102)
- Cumulative cohort design for dose-finding (2007) (98)
- Early oral changes following bone marrow transplantation. (1988) (94)
- Cell-mediated immunity to varicella-zoster virus after allogeneic marrow transplant. (1980) (93)
- Cure of leukemia by marrow transplantation (1977) (89)
- Prophylactic use of human leukocyte interferon after allogeneic marrow transplantation. (1987) (87)
- The risks of central nervous system relapse and leukoencephalopathy in patients receiving marrow transplants for acute leukemia (1986) (80)
- Asymptotic normality of maximum likelihood estimators from multiparameter response-driven designs (1997) (80)
- Estimating the probability of toxicity at the target dose following an up‐and‐down design (2003) (77)
- Marrow transplantation for children in first remission of acute nonlymphoblastic leukemia: an update. (1985) (77)
- Experimental radioimmunotherapy of murine lymphoma with 131I-labeled anti-T-cell antibodies. (1986) (71)
- Development and validation of a measure of dysmorphology: Useful for autism subgroup classification (2008) (70)
- Oral and pharyngeal herpes simplex virus infection after allogeneic bone marrow transplantation: analysis of factors associated with infection. (1990) (70)
- Marrow transplant experience in children with acute lymphoblastic leukemia: an analysis of factors associated with survival, relapse, and graft-versus-host disease. (1985) (69)
- Immunological recovery in 48 patients following syngeneic marrow transplantation or hematological malignancy. (1982) (66)
- Marrow transplantation for patients with acute lymphoblastic leukemia: a long-term follow-up (1983) (66)
- Rapid diagnosis of cytomegaloviral pneumonia by tissue immunofluorescence with a murine monoclonal antibody. (1985) (65)
- Asymptotics in response-adaptive designs generated by a two-color, randomly reinforced urn (2009) (56)
- Up-and-down designs. I. Stationary treatment distributions (1995) (56)
- Early and late interstitial pneumonia following human bone marrow transplantation. (1986) (53)
- Group up-and-down designs for dose-finding (2006) (53)
- Estimating Random Effects In the Framingham Heart Study (1992) (52)
- SEQUENTIAL INTRAVENOUS AND TWICE‐DAILY ORAL ACYCLOVIR FOR EXTENDED PROPIIZLAXIS OF HEAPFA SIMPLEX VIRUS INFECTION IN MARROW TRANSPIANT PATIENTS (1987) (50)
- Allogeneic marrow transplantation for acute leukemia in relapse. (1982) (47)
- A Clinical Experiment in Bone Marrow Transplantation: Estimating a Percentage Point of a Quantal Response Curve (1993) (46)
- Additive Hazards Model for Competing Risks Analysis of the Case-Cohort Design (2004) (37)
- The risks of central nervous system relapse and leukoencephalopathy in patients receiving marrow transplants for acute leukemia. (1986) (33)
- An adaptive design for maximization of a contingent binary response (1995) (32)
- Adaptive Designs (2001) (32)
- Quantile estimation following non‐parametric phase I clinical trials with ordinal response (2004) (30)
- UP-AND-DOWN DESIGNS II: EXACT TREATMENT MOMENTS (1995) (30)
- An Optimizing Up-and-Down Design (2001) (26)
- Statistical Multiple Integration (1991) (25)
- A Birth and Death Urn for Ternary Outcomes: Stochastic Processes Applied to Urn Models (2000) (25)
- Once-daily intravenous acyclovir for prophylaxis of herpes simplex virus reactivation after marrow transplantation. (1985) (23)
- Information in a two-stage adaptive optimal design (2014) (23)
- Pulmonary function of marrow transplant patients. I. Effects of marrow infusion, acute graft-versus-host disease, and interstitial pneumonitis. (1984) (22)
- Toxicity in sequential dose-response experiments (1995) (21)
- Relapse Following Marrow Transplantation for Acute Leukemia (1978) (21)
- Assessment of Dependence In the Life Times of Twins (1992) (20)
- Energy expenditure estimation in recipients of marrow transplants (1984) (20)
- Two-Stage Adaptive Optimal Design with Fixed First-Stage Sample Size (2012) (17)
- Aggressive adriamycin‐containing regimen (PM‐FAC) in estrogen receptor‐negative disseminated breast cancer. Results of a southwest oncology group trial (1985) (16)
- Simultaneous infusion of high-dose cytosine arabinoside with cyclophosphamide followed by total body irradiation and marrow infusion for the treatment of patients with advanced hematological malignancy. (1988) (16)
- A BIRTH AND DEATH URN FOR RANDOMIZED CLINICAL TRIALS: ASYMPTOTIC METHODS (2016) (15)
- Do small trials square with large ones? (1995) (15)
- A Graphical Comparison of Response-Adaptive Randomization Procedures (2013) (15)
- Plasma fatty acid patterns of bone marrow transplant patients primarily supported by fat-free parenteral nutrition. (1981) (14)
- Autologous Marrow Transplantation for Malignant Lymphoma (1986) (13)
- Centered Isotonic Regression: Point and Interval Estimation for Dose–Response Studies (2017) (13)
- Restricted optimality for phase I clinical trials (1998) (13)
- Comparison of Isotonic Designs for Dose-Finding (2009) (13)
- Asymptotically Optimal Response‐Adaptive Designs for Allocating the Best Treatment: An Overview (2012) (12)
- Marrow transplantation for patients with acute lymphoblastic leukemia: a long-term follow-up. (1983) (11)
- The focused information criterion for varying-coefficient partially linear measurement error models (2016) (10)
- Optimal experimental design for systems with bivariate failures under a bivariate Weibull function (2015) (10)
- Optimal Designs for Contingent Response Models (2004) (9)
- Random norming aids analysis of non-linear regression models with sequential informative dose selection (2019) (9)
- Recurrence of acute leukemia more than two years after allogeneic marrow grafting. (1986) (9)
- Up-and-Down Designs for Selecting the Dose with Maximum Success Probability (2008) (8)
- Convergence Results for an Adaptive Ordinal Urn Design (1993) (7)
- Asymptotic properties of maximum likelihood estimators with sample size recalculation (2019) (7)
- Bias induced by adaptive dose-finding designs (2019) (7)
- Optimal designs for response functions with a downturn (2011) (6)
- Development Of A Pipeline Leak Detector (1978) (6)
- Advances in the Mathematical Sciences (2016) (6)
- Optimal designs for contingent response models with application to toxicity–efficacy studies (2013) (5)
- Estimands and their Estimators for Clinical Trials Impacted by the COVID-19 Pandemic: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions (2023) (5)
- Distribution theory following blinded and unblinded sample size re-estimation under parametric models (2019) (5)
- Most powerful test sequences with early stopping options (2021) (5)
- Quality control for a shared multidisciplinary database (1991) (5)
- On Testing Hypotheses in Response-Adaptive Designs Targeting the Best Treatment (2010) (5)
- Group Up‐and‐Down Designs in Toxicity Studies (2006) (5)
- New developments and applications in experimental design : selected proceedings of a 1997 Joint AMS-IMS-SIAM summer conference (1998) (5)
- Information in a Two-stage Adaptive Optimal Design for Normal Random Variables having a One Parameter Exponential Mean Function (2010) (5)
- Understanding Research Methods: Up-and-down Designs for Dose-finding. (2022) (4)
- A new bounded log-linear regression model (2014) (4)
- Conditional Inference in Two-Stage Adaptive Experiments via the Bootstrap (2016) (4)
- On the consistency of the maximum likelihood estimator for the three parameter lognormal distribution (2015) (4)
- Discussion on the papers on 'Elicitation' (1998) (4)
- Evaluation of development traits of beef buffalo in Brazil using multivariate analysis (2007) (4)
- A procedure for finding an improved upper bound on the number of optimal design points (2013) (4)
- Sharing scientific data III: planning and the research proposal. (1990) (4)
- Up‐and‐Down Designs (2014) (4)
- An estimate of the recombination frequency between the B locus and the D locus within the major histocompatibility complex. (1976) (3)
- Bivariate Markov chains containing a failure process (1990) (3)
- Results of Allogeneic Marrow Transplantation in Patients Transplanted for Acute Leukemia: A Long-Term Follow-Up (1986) (3)
- A Conversation with Wilfrid J. Dixon (1993) (3)
- Am J Med Genet Part A 146A:1101–1116 Development and validation of a measure of dysmorphology: Useful for autism subgroup classification (2008) (3)
- Adaptive Sampling Designs. (1989) (3)
- Adaptive designs : selected proceedings of a 1992 joint AMS-IMS-SIAM summer conference (1995) (3)
- Randomization Based Inference for the Drop-The-Loser Rule (2013) (3)
- Rejoinder: Estimands and their Estimators for Clinical Trials Impacted by the COVID-19 Pandemic: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions (2022) (3)
- Aggressive doxorubicin-containing regimen (prednisone, methotrexate, 5-FU, doxorubicin, and cyclophosphamide; PM-FAC) in disseminated estrogen receptor-negative breast cancer. (1984) (2)
- The Effects of Adaptation on Inference for Non-Linear Regression Models with Normal Errors (2018) (2)
- Analysis of Trials with Treatment — Individual Interactions (1992) (2)
- Effect of Interim Adaptations in Group Sequential Designs. (2019) (2)
- Fain following intensive chemoradiotherapy and bone marrow transplantation (EMT) (1984) (1)
- RESPONSE-DRIVEN URN DESIGNS: COMMENT ON “RANDOMIZED URN MODELS AND SEQUENTIAL DESIGN” BY W. F. ROSENBERGER (2002) (1)
- Advances in the Mathematical Sciences : Research from the 2015 Association for Women in Mathematics Symposium (2016) (1)
- remission Marrow transplantation for patients with acute lymphoblastic leukemia in (2011) (1)
- Design Considerations for Two Stage Enrichment Clinical Trials. (2022) (1)
- Adaptive Designs (Lecture Notes Monograph Series, Vol. 25). (1997) (1)
- A Ballooned Beta-Logistic Model (2017) (1)
- University of Missouri Department of Statistics (2012) (1)
- Inference for a two-stage enrichment design (2021) (1)
- Effects of Database Management on the Organization and Administration of Clinical Trials (1981) (1)
- Technical Report No. 2000-2: A New Approach to Dose Finding for Phase I Clinical Trials (AU-CAS-MathStats) (2014) (1)
- Discussion on “Adaptive enrichment designs with a continuous biomarker” by Nigel Stallard (2022) (1)
- Asymptotic properties of maximum likelihood estimators with sample size recalculation (2019) (1)
- Dependency in multivariate markov chains (1990) (1)
- Coping with Information Loss and the Use of Auxiliary Sources of Data: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions (2022) (1)
- Performance Measures in Dose‐Finding Experiments (2020) (1)
- The effects of adaptation on maximum likelihood inference for nonlinear models with normal errors (2021) (0)
- Choosing Interim Sample Sizes in Group Sequential Designs (2021) (0)
- Optimal Design for the Bounded Log-Linear Regression Model (2013) (0)
- The focused information criterion for varying-coefficient partially linear measurement error models (2014) (0)
- The NISS Ingram Olkin Forum on Unplanned Clinical Trial Disruptions (2023) (0)
- COMSYS 1 Intervals Between Testing and Mailing Criterion Exercises in the 1971-72 IMS Tryout. (1972) (0)
- Collection of IMS Time Evaluation Data. (1972) (0)
- A Graphical Method for Comparing Response-Adaptive Randomization Procedures (2012) (0)
- Design and Analysis of Experiments 2012 (2012) (0)
- A New Tool for Comparing Adaptive Designs; a Posteriori Efficiency (2007) (0)
- long-term follow-up Marrow transplantation for patients with acute lymphoblastic leukemia: a (2011) (0)
- Corruption of the Scientific Method (2013) (0)
- Statistical Multiple Integration: Proceedings of a Joint Summer Research Conference Held at Humboldt University, June 17-23, 1989 (1991) (0)
- Phase I Clinical Trials (2007) (0)
- 2 PHASE I TRIALS IN HEALTHY VOLUNTEERS (2007) (0)
- Are There Leaks in Your Product Pipeline (2010) (0)
- The Efficiency of Randomized Discontinuation Trials with Continuous Responses (2011) (0)
- A new bounded log-linear regression model (2013) (0)
- On dose-response modeling for evaluation of drugs combinations (2023) (0)
- Multivariate Optimizing Up and Down Design (2001) (0)
- Exact Distributions of Sequential Threshold Estimators (1998) (0)
- Bayesian Methods in Auditing (1996) (0)
- Group sequential tests: beyond exponential family models (2023) (0)
- body irradiation, and allogeneic marrow transplantation One hundred patients with acute leukemia treated by chemotherapy, total (2011) (0)
- 2011 Summer School on Statistical Experimental (2011) (0)
- Results of allogeneic marrow transplantation in patients transplanted for leukemia: A five year follow-up (1986) (0)
- Posterior alternatives with informative early stopping (2023) (0)
- IMS Version 3 1971-72 Tryout: Initial Report on COMSYS 1 and 2 Computer Operations. (1972) (0)
- [How to Get Your First Research Grant]: Comment (1989) (0)
- patients receiving marrow transplants for acute leukemia The risks of central nervous system relapse and leukoencephalopathy in (2011) (0)
- The Cost of Sequential Adaptation and the Lower Bound for Mean Squared Error (2022) (0)
- Up-and-down designs (2013) (0)
- nonlymphoblastic leukemia: an update Marrow transplantation for children in first remission of acute (2011) (0)
This paper list is powered by the following services:
Other Resources About Nancy Flournoy
What Schools Are Affiliated With Nancy Flournoy?
Nancy Flournoy is affiliated with the following schools:
